Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)

News

Don Manvel Elected to Karmanos Cancer Institute’s Board of Directors

The Barbara Ann Karmanos Cancer Institute (KCI) is pleased to announce the election of Don Manvel to its Board of Directors. Manvel will serve a three-year term. 

Members of the KCI board are dedicated to providing strategic direction as Karmanos moves toward the goal of serving as one of the nation’s top 10 National Cancer Institute-designated comprehensive cancer centers. 

Manvel is chairman and CEO of the North American operations of AVL, the recognized leader in developing clean and efficient technologies to fuel the world. Under his leadership, AVL Americas has grown significantly on this continent, becoming well known for the next-generation technological and engineering solutions it provides for its blue-chip OEM customers. 

Prior to joining AVL, Manvel held a variety of senior executive positions in various parts of the world. He worked closely with Dean Kamen, founder of Segway Inc., on the development of the first self-balancing, electronic transportation device – the Segway Human Transporter. While at the former Chrysler Corp., he was a member of the group that engineered the successful bailout and turnaround of this automotive icon. He also helped orchestrate the merger of Daimler and Chrysler in South America and was responsible for helping make Jeep Grand Cherokee one of the company’s leading global brands.

Manvel holds a master’s of business administration from Wayne State University. He is a passionate advocate of organizations that are searching for a cancer cure, as well as educational and technological groups and foundations. Manvel, a well-known patron of the Greater Detroit community, resides in Birmingham.


© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.